FDA Inspection 1069130 — Center For Fertility And Reproductive Endocrinology UPP
The FDA completed an inspection of Center For Fertility And Reproductive Endocrinology UPP on Aug 8, 2018 in Pittsburgh, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 8, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Pittsburgh, PA (United States)